A Supramolecular Nanoscavengers: Based “Cargo‐Exchange” Breaking Cholesterol Metabolic Dysregulation for Glioblastoma Therapy
Advanced Science · 2026
DOI: 10.1002/advs.202519690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Zonghua Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery Ministry of Education, State K…. Hauptthemen laut MEDLINE: Glioblastoma, Cholesterol, beta-Cyclodextrins, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, ZJLab and the Open Grant from the Pingyuan Laboratory.
Abstract (Originalsprache)
Dysregulated cholesterol metabolism, driven by a complex array of mechanisms, is a defining characteristic of glioblastoma (GBM) and plays a crucial role in the development of resistance to therapeutic interventions. In this study, supramolecular nanoscavengers are engineered by harnessing the intrinsic binding affinity between endogenous small‐molecule cholesterol and β‐cyclodextrin (β‐CD). This host‐guest interaction enabled both targeted drug release and cholesterol clearance through competitive displacement within the cholesterol‐rich microenvironment of GBM. Consequently, tumor‐associated cholesterol dysregulation is effectively disrupted, resulting in significant inhibition of cellular proliferation and invasion. Furthermore, the supramolecular nanoscavengers interfered with the metabolic crosstalk between tumor cells and immune cells involving cholesterol, thereby remodeling the immunosuppressive tumor microenvironment and demonstrating substantial therapeutic efficacy in vivo. Additionally, the dynamic and reversible binding between β‐CD and various guest molecules facilitated efficient delivery of the supramolecular host to the central nervous system (CNS). Collectively, these findings presented a promising strategy for targeting cholesterol as an intervention in the treatment of GBM as well as other CNS disorders associated with altered cholesterol metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery Ministry of Education, State Key Laboratory of Brain Function and Disorders, Shanghai, 201203, China.
ORCID-Profile: Tao Sun
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
- ZJLab and the Open Grant from the Pingyuan Laboratory
Zitieren
APA
Tian, Z., Chen, Y., Zhou, J., Zhang, S., Fan, H., Li, X., Sun, T., & Jiang, C. (2026). A Supramolecular Nanoscavengers: Based “Cargo‐Exchange” Breaking Cholesterol Metabolic Dysregulation for Glioblastoma Therapy. Advanced Science. https://doi.org/10.1002/advs.202519690
Vancouver
Tian Z, Chen Y, Zhou J, Zhang S, Fan H, Li X, et al. A Supramolecular Nanoscavengers: Based “Cargo‐Exchange” Breaking Cholesterol Metabolic Dysregulation for Glioblastoma Therapy. Advanced Science. 2026. doi:10.1002/advs.202519690
BibTeX
@article{Tian2026,
author = {Tian, Zonghua and Chen, Yun and Zhou, Jingyi and Zhang, Shilin and Fan, Hongrui and Li, Xuwen and Sun, Tao and Jiang, Chen},
title = {A Supramolecular Nanoscavengers: Based “Cargo‐Exchange” Breaking Cholesterol Metabolic Dysregulation for Glioblastoma Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202519690}
}
EUVIMED